Fresenius Medical Care Ag · XETR:FME
Fresenius Medical Care — Investor Day (June 2025)
9 slides from Fresenius Medical Care's investor day presentation, Jun 17, 2025
Slide 1: Deep-dive breakout session: Care Delivery
Deep-dive breakout session Care Delivery Craig Cordola Ed.D., CEO Care Delivery London | June 17, 2025 Fresenius Medical Care
Slide 2: Safe harbor statement
Safe harbor statement: In this Safe harbor statement, “the Company” and “Fresenius Medical Care” refer to Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares, prior to its conversion of legal form, and to Fresenius Medical Care AG, a German stock corporation, after its conve
Slide 3: Care Delivery | Advancing to industry-leading margins by 2030
Reignite Care Delivery | Advancing to industry-leading margins by 2030 Value € Creation Path to mid-teens operating margin aspiration Mid-teens 11.4% (Increasing inflow) Increasing patient new starts (Reducing outflow) Patient quality and safety, retention (Reducing outflow) U.S. HVHDF rollout Reali
Slide 4: Accelerating Growth in the Core: Making it easy for patients to choose us
Reignite Accelerating Growth the Core Making it easy for patients to choose us every day Growth acceleration program targets four areas Build a culture to recruit and retain Design and pilot solutions for the future direct patient care staff to alleviate 1 state of patient access, spanning: 2 clinic
Slide 5: Enhancing quality and patient safety
Reignite Enhancing quality and patient safety Growth & Patient growth through leading clinical outcomes innovation Three near-term focus areas Optimize time Improve fluid Reduce CVCs on dialysis management and BSIs ▪ Promote patient ▪ Chairside fluid ▪ Fewer central venous treatment adherence decisi
Slide 6: Improving Realized Dialysis Rates in the Core: Triad approach
Reignite Improving Realized Dialysis Rates the Core Triad approach to driving results MIX RATE REALIZATION Payor and service mix Reimbursement Payment collections ▪ Number of patients across each payor ▪ Rates established by the U.S. ▪ The portion of reimbursement type (Commercial, Medicare, etc.) G
Slide 7: Introducing HVHDF to the U.S.
Reignite Introducing HVHDF to the U.S. Growth & Transforming the standard of dialysis care in the U.S. market innovation 5008X launch has potential to improve patient care and accelerate sustainable Care Delivery growth Key benefits to Care Delivery Innovative therapy with potential to improve patie
Slide 8: We lead kidney care through exceptional patient care and innovation
We lead kidney care through exceptional patient care and innovation Fresenius Medical Care
Slide 9: Contacts
Contacts Fresenius Medical Care AG Investor Relations Else-Kröner-Str. 1 61352 Bad Homburg v. d. H. Germany Dr. Dominik Heger Ilia Kuerten Alicia Cahill ir@FreseniusMedicalCare.com Head of Investor Relations Vice President Senior Director and Investor Relations Investor Relations Ticker: Head of I